Titan Biotech Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)
Titan Biotech Ltd · Financial Result · 05 Nov 2026, 9:09 pm
Titan Biotech Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 7,646 (+40.7% YoY | +29.2% QoQ) ■ EBITDA: 1,501 (+60.9% YoY | +20.2% QoQ) ■ EBITDA Margin (%): 19.6 (+247 bps YoY | -147 bps QoQ) ■ PAT: 1,255 (+61.6% YoY | +15.6% QoQ) ■ EPS (INR): 3.04 (-67.7% YoY | +15.6% QoQ)
Original exchange filing (PDF)
More announcements from Titan Biotech Ltd
- Outcome of Board Meeting · 05 Nov 2026
- Titan Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve Unaudited Financial Results for .... · 05 Nov 2026
- Allotment of 1,03,29,625 Fully Paid Up Bonus Equity Shares of Rs. 2/- each to Shareholder holding shares on 23rd October, 2026 (record Date) · 26 Oct 2026
- The Company has fixed record date as Friday, October 23, 2026 for ascertaining the eligibility of Shareholders entitled for allotment of Bonus Equity Shares in the ratio of 1:4 and deemed .... · 09 Oct 2026
- Alteration of the Clause 5 i.e. Capital Clause of the Memorandum of Association (MOA) of the Company · 30 Sept 2026
- Voting results and Scrutinizers Report for 34th Annual General Meeting of the Company · 30 Sept 2026
- Proceedings of 34th Annual General Meeting of Titan Biotech Limited · 30 Sept 2026
- The Company has sent Letters to those members who have not registered their email address with the Company/RTA/ Depository providing a weblink including exact path of Website to access .... · 05 Sept 2026
